China Polycarbonate for Medical Use Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$3250$7500

Polycarbonate is a lightweight, high-performance thermoplastic polymer with a rare combination of excellent electrical resistance, dimensional flexibility, optical clarity, high heat resistance, and durability.

Description

China Polycarbonate for Medical Use Market By Technology (Extrusion, Blow Molding And Injection Molding) By Application (Fluid Delivery & IV Connection Components, Renal Dialysis Products, Cardiovascular Devices, Surgical Instruments and Others) and Region –Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030.
Product Overview
Polycarbonate is a lightweight, high-performance thermoplastic polymer with a rare combination of excellent electrical resistance, dimensional flexibility, optical clarity, high heat resistance, and durability. Polycarbonate has wide applications due to its flexible property, and high usage. Polycarbonate is also placed between engineering plastics and commodity plastics because of its high use. Polycarbonate is most commonly synthesized from bisphenol-A and phosgene through a process of step-growth polymerization, also known as the process of condensation.
Market Highlights
China Polycarbonate for Medical Use Market size was registered at USD XX billion in 2019 and is estimated to reach USD XX billion by 2030, registering a CAGR of XX% from 2020 to 2030. Medical polycarbonate’s properties such as its excellent transparency, biocompatibility, high impact resistance, and strength make medical polycarbonate an ideal material for formulating fluid delivery & IV contact components, renal dialysis products, cardiovascular devices, surgical instruments, and medical packaging, lenses, catheters, syringes, thereby boosting market development.
China Polycarbonate for Medical Use Market: Segments
China Polycarbonate for Medical Use Market is segmented on the basis of technology, application and region.
By Technology (in %), China Polycarbonate for Medical Use Market, 2019
The injection molding segment is anticipated to register XX% of the market share during the forecasted period.
By technology, the market can be segmented into extrusion, blow molding and injection molding. Economic advantages of high-speed and high-volume production of injection molding technology to drive the demand for the segment in the market.
China Polycarbonate for Medical Use Market Dynamics:
Use in treatments and diagnosis and rising target health incidents to increase market growth
Medical polycarbonate’s properties such as its excellent transparency, biocompatibility, high impact resistance, and strength make medical polycarbonate an ideal material for formulating fluid delivery & IV contact components, renal dialysis products, cardiovascular devices, surgical instruments, and medical packaging, lenses, catheters, syringes, thereby boosting market development.
Bisphenol-A detection in polycarbonate to hinder the market growth in China

The detection of bisphenol-A (BPA) in packaging materials and medical applications is a major restraint in the polycarbonate market.
China Polycarbonate for Medical Use Market: Regions
In terms of value and volume, China accounted for XX% of total market volume share in 2019
The prominent factors projected to drive the medical polycarbonate market in this area are the rise in funding from governments of various countries such as China and growth in foreign direct investment in the medical industry. Medical polycarbonate manufacturers in China are also expanding their production facilities to meet the increasing demand for medical polycarbonate in the region-wide medical sector. That is also likely to propel the demand for medical polycarbonate.

China Polycarbonate for Medical Use Market: Competitive landscape
Some factors that improve the role in the market of the key players within the China Polycarbonate for Medical Use Market have been the improvement in healthcare facilities among key players and availability of favorable reimbursement policies and FDA approvals in developing regions coupled with the growth in preference for polycarbonate products.
China Polycarbonate for Medical Use Market: Key players

• Chi Mei Corp.
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• Covestro
• Formosa Plastics
• Idemitsu Kosan
• LG Chem
• Lotte Chemical Corporation
• Mitsubishi Engineering Plastics
• SABIC
• Samyang
• Other prominent players
China Polycarbonate for Medical Use Market report also contains analysis on:

China Polycarbonate for Medical Use Market segments:-

• By Technology:
o Injection molding
o extrusion
o blow molding

• By Application:
o Fluid Delivery & IV Connection Components
o Renal Dialysis Products
o Cardiovascular Devices
o Surgical Instruments
o Others

• China Polycarbonate for Medical Use Market dynamics
• China Polycarbonate for Medical Use Market size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

1. Executive Summary
2. China Polycarbonate for Medical Use Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Market Dynamics
5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends
6. Correlation & Regression Analysis
6.1. Correlation Matrix
6.2. Regression Matrix
7. Recent Development, Policies & Regulatory Landscape
8. Risk Analysis
8.1. Demand Risk Analysis
8.2. Supply Risk Analysis
9. China Polycarbonate for Medical Use Market Analysis
9.1. Porters Five Forces
9.1.1. Threat of New Entrants
9.1.2. Bargaining Power of Suppliers
9.1.3. Threat of Substitutes
9.1.4. Rivalry
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. China Polycarbonate for Medical Use Market
10.1. Market Size & forecast, 2019A-2030F
10.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11. China Polycarbonate for Medical Use Market: Market Segmentation

11.1.1. East China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. South China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.3. North China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.4. West China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12. China Polycarbonate for Medical Use Market: Market Segmentation
12.1. By technology: Market Share (2020-2030F)
12.1.1. Extrusion, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Blow molding, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Injection molding, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By application : Market Share (2020-2030F)
12.2.1. Fluid Delivery & IV Connection Components, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Renal Dialysis Products, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Cardiovascular Devices , By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.4. Surgical Instruments, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.5. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

13. Company Profile
13.1. Chi Mei Corp.
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Covestro
13.3. Formosa Plastics
13.4. Idemitsu Kosan
13.5. LG Chem
13.6. Lotte Chemical Corporation
13.7. Mitsubishi Engineering Plastics
13.8. SABIC
13.9. Samyang
13.10. Other prominent players

14. Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.